McKesson Corporation MCK
866.64
(2.72)
(0.31%)
as of 25 Sep
- Market cap
- $101.8B
- P/E
- 23.1×
Follow MCK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
McKesson Corporation (MCK) Return on equity
McKesson Corporation's return on equity over the twelve months to 30 June 2026 was −168.5%, up 105.9 percentage points from fiscal 2026 (−274.4%). Over the past ten years it has ranged from −274.4% (fiscal 2026) to 50.0% (fiscal 2017) — the current reading is the lowest in ten years. That is below the Medical Distribution industry median of 0.00% and below the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | −274.4% | (74.27) |
| FY2025 | −200.1% | (5.75) |
| FY2024 | −194.4% | 22.57 |
| FY2023 | −216.9% | (79.15) |
| FY2022 | −137.8% | 27.75 |
| FY2021 | −165.5% | (178.78) |
| FY2020 | 13.2% | 12.87 |
| FY2019 | 0.37% | (0.26) |
| FY2018 | 0.63% | (49.37) |
| FY2017 | 50.0% | 23.58 |
Against its own ten years
Low −274.4%
High 50.0%
Ten-year median
−68.7%
Current reading's percentile
8
Return on equity against peers
| Company | Return on equity |
|---|---|
| COR Cencora, Inc. compare | 96.3% |
| ACH Accendra Health, Inc. compare | 72.6% |
| YI 111, Inc. Sponsored ADR compare | 12.3% |
| HSIC Henry Schein, Inc. compare | 10.2% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| CAH Cardinal Health, Inc. compare | −64.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation | −168.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MCK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement